NYU Neurogenetics — New York, New York

NYU Neurogenetics is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Neurogenetics has participated in 1 clinical trials.

Therapeutic areas: Late-onset Pompe Disease.

Sponsors: Amicus Therapeutics.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Neurogenetics?

NYU Neurogenetics has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Neurogenetics conducted?

NYU Neurogenetics has 1 clinical trials on record. Their work covers Late-onset Pompe Disease.

Is NYU Neurogenetics accredited by Crixeo Health?

NYU Neurogenetics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Neurogenetics?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.